Regeneron Pharmaceuticals said Monday it will acquire 23andMe’s DNA testing business and most of its assets out of bankruptcy and pledged to continue offering the popular consumer service and adopt ...
For more than 20 years, Wisdom Panel has harnessed the power of genetics to shape the future of pet health and deepen the bond between people and pets. FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Wisdom ...
May 19 (Reuters) - Drugmaker Regeneron Pharmaceuticals (REGN.O), opens new tab is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling ...
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...
TEL AVIV, Israel & LEHI, Utah--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today the release of Ancient Origins, a major new product that ...
The genetic DNA testing firm 23andMe filed for Chapter 11 bankruptcy Sunday, leaving many customers wondering how their data will be protected. The bankruptcy filing comes as the company has struggled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results